PDCD1 and acute myeloid leukemia: Another study demonstrated that PD‐1 blockade was able to increase the expression of IFN‐γ in γδ T cells, thus enhancing their anti‐tumour capacity against AML cells, further suggesting the efficacy of γδ T‐cell immunotherapy in combination with checkpoint inhibitors.61